Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good stuff. "Industry investment" particularly for developing a nasal application. Go IPIX
"Brilacidin for prophylactic use, including assessing Brilacidin in pre-clinical animal models, is of particular interest due to Brilacidin's blocking and neutralizing antiviral properties and industry investment in developing intranasal-targeted, direct-acting antivirals."
Hopefully all this pulls in research grant money. We know the NIH has been studying B on other nasty viruses as well.
Likely just a reiteration of past boogeyman sentiment. The positive sentences strongly counter that notion. As we wait for the next update negativity gains a foot hold.
3. "Asset procurement, and or negotiations of licensing deals, business transactions such and partnership and or mergers are still ongoing since all data has been collected and reviewed. Has anyone ever seen a deal with multiple biotechs take 30-90 days to accomplish"?
Right now it's a Boogeyman concoction putting that idea in investors heads. Anything that spins negative throw it against the wall like spaghetti.. We wait for more IPIX news.
January 25. Not 3 months but five weeks ago. I don't know the whens but I have bought more shares. Gods grace.
I rather like this quote: "Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned". Go Leo.
The shortly statement was directed at CU and the trial. Clearly things are taking longer then Leo was likely told. Last 10q statement said they would be receiving data late February so any day now.
"The Company will be providing shortly an update based on further data analysis of the Brilacidin Phase 2 COVID-19 study results and compassionate use of Brilacidin in critically-ill hospitalized COVID-19 cases".
Yes Covid-19 has been declared pretty much over but collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing according to Leo's January update and generating promising data, with future updates planned. I think this our strong suite. Still a lot of nasty viruses out there with a need for treatment.
Just have to wait and see if we get a term sheet.
$12.49 sounding good now.
And sometimes even supported by public message boards. One can't be too careful of the mako's of the world. As others I'm looking forward to Leo's next update.
a scam involves criminal activity.
The C party will be ongoing for quite sometime. Biden admin is seeking another 30Billion in covid funding.
https://www.stripes.com/covid/2022-02-16/biden-administration-30-billion-request-for-COVID-funding-5037118.html
Got that right and signing bonus paid out in 2021 would trigger a payroll tax increase. Go new hire.
Per 10q there's a new hire. Payroll increase due to a new hire of an employee during the first quarter of 2022.
Oh yeah with a deal were back to just nitpicking which is alright.
It will never end so why bother. Lets see what Leo brings in the next update.
I say likely all were on heparin blood anti-coagulant in the hospital setting but we need a full report on this to know. Now that we know heparin decreases B's effectiveness in effect it amounts to a reduction in the dosage.imo
I remember Dr Missling stating that A-273 could possibly help with controlling AFIB which is a huge market in itself. Sodium channel blockers and the like have negative safety profiles.
I'm betting Leo finds government funding as viral testing continues. Of course a great license deal to further B should be the goal. imo
So yesterdays notice went out late.lol It's a dirty business.
Speak control. George Orwell would say I told you so.
"Innovation management is engaged in discussions potentially to acquire rights to new pipeline assets, as well as to enter into new licensing agreements". Go Leo!
"Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned".
Back to $30.00 going to need another big bag. Holding for a couple hundred.
Nov18- "More broadly, evaluation of Brilacidin’s broad-spectrum antiviral properties continues through collaborations with NIH scientists and academic researchers, and may introduce opportunities to study Brilacidin in neglected tropical diseases. The Company plans to announce new findings as they are reported to us".
Yes research is ongoing.
New pipeline assets, as well as to enter into new licensing agreements. Get it Leo.
Your right nothing to see here.
Excellent. So we have real world confirmation Rett Syndrome News seems to me. Thanks for posting.
Business update on next leg up. Deals take time.
I want the stock price to move up from here. Some want the stock price to move down so they can re-enter. Will 2 cents happen likely not within the next few weeks as Leo said news shortly..
Share price found it's footing. Solid 6% move.
Antibiotics are the bees knees if given early enough. B is being further studied for a reason this we know.
Got some nice traction off .038. Somebody's buying.
Somebody getting in bigly. Let's go.
It was a worthy "share holder" news letter. The broader public lol
They will be too upset.
Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned.
You are correct is my belief also. My opinion is one hallmark of a scam is they never produce an IND for trial. IPIX has run multiple FDA approved trials.
Share holder update. What ever they're incubating it's not quite finished.
There was a lot in that Dec 7 pr, it's now Jan 24. Should get an update on all the government testing. Really like to see a term sheet.
I just hope we get some solid news next cycle. Fluff is not going to cut it.
I agree somethings cooking. Looking forward to the next update.
Leo's likely working to provide solid a update, for that I don't mind this quiet period. I don't want some fluff pr stating they are laser focused on multiple fronts or some such nonsense.
Somebody purposely cuts the ask. Pay the ask and you get the shares below the ask.